FDA clears Medtronic products for diagnostic cardiac catheterization procedures, PCIs

Tim Casey | | Cardiovascular Business | Interventional Cardiology

The FDA cleared Medtronic’s DxTerity diagnostic angiography catheter line and several of the company’s transradial-specific products, all of which are used in diagnostic cardiac catheterization procedures and PCIs.

The transradial-specific products include the DxTerity TRA, InTRAkit access kit and TRAcelet compression device.

Medtronic announced the approvals in a Feb. 13 news release. The products also received a CE Mark for use in Europe.

Medtronic said the DxTerity and DxTerity TRA diagnostic catheters determine if patients with coronary artery disease require revascularization. The DxTerity TRA is designed for transradial access.

Meanwhile, the InTRAkit includes ergonomic needles, atraumatic min-guidewires and tapered introducer sheaths that enhance the transradial experience. In addition, the TRAcelet compression device provides access site patent hemostasis.

Medtronic also launched the Transradial Arc Curriculum, an education and training program in the U.S. The curriculum is intended to allow physicians, staff and administrators to adopt the transradial approach. The company said randomized trials have found the transradial approach was associated with cost savings, reduced mortality and reductions in major bleeding and vascular complications.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Related Content

First patient treated with transcatheter heart failure device to reduce LV size
Angiographic catheters recalled due to safety risk
TAVR patients with moderate or greater TR may face increased risks
Robotic heart surgery represents a key step forward for SS Innovations
Late-breaking clinical trials announced for New York Valves 2025
Next-day discharge after TAVR is still safe when alternative access is required

Around the web

Health Exec
Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

Radiology Business
U.S. iodine contrast supply may not be subject to proposed 25% tariffs

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.